Physician profile
Kathryn Keefer
NPI 1225591050
$862.88
in general payments reported to CMS, 2019-2025
9 companies · $13.91 in 2025
The $13.91 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $66.20 · 2021: $227 · 2022: $488 · 2023: $16.36 · 2024: $51.28 · 2025: $13.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.59 | 2022-2025 | |
| Glaxosmithkline, LLC. | $96.66 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.02 | 2022 | |
| Pfizer INC. | $68.68 | 2021-2024 | |
| Gilead Sciences, INC. | $52.15 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.40 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.47 | 2022 | |
| Novo Nordisk INC | $17.41 | 2024 | Ozempic, Rybelsus |
| Ultragenyx Pharmaceutical INC. | $14.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Keefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.